COVID-19 With Preexisting Hypercoagulability Digestive Disease

The outbreak of coronavirus disease of 2019 (COVID-19) has become a global public health and economic crisis. The advent of hypercoagulability and thrombotic complications can substantially influence the prognosis of COVID-19 patients. In this review, we elaborate on the clinical findings, potential...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Mingshan, Mu, Jingxi, Shen, Silan, Zhang, Hu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838325/
https://www.ncbi.nlm.nih.gov/pubmed/33521013
http://dx.doi.org/10.3389/fmed.2020.587350
_version_ 1783643150199291904
author Jiang, Mingshan
Mu, Jingxi
Shen, Silan
Zhang, Hu
author_facet Jiang, Mingshan
Mu, Jingxi
Shen, Silan
Zhang, Hu
author_sort Jiang, Mingshan
collection PubMed
description The outbreak of coronavirus disease of 2019 (COVID-19) has become a global public health and economic crisis. The advent of hypercoagulability and thrombotic complications can substantially influence the prognosis of COVID-19 patients. In this review, we elaborate on the clinical findings, potential underlying pathogenesis, and therapeutic strategy of hypercoagulability and thromboembolism in COVID-19, particularly focusing on the COVID-19 patients with preexisting digestive hypercoagulability disease.
format Online
Article
Text
id pubmed-7838325
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-78383252021-01-28 COVID-19 With Preexisting Hypercoagulability Digestive Disease Jiang, Mingshan Mu, Jingxi Shen, Silan Zhang, Hu Front Med (Lausanne) Medicine The outbreak of coronavirus disease of 2019 (COVID-19) has become a global public health and economic crisis. The advent of hypercoagulability and thrombotic complications can substantially influence the prognosis of COVID-19 patients. In this review, we elaborate on the clinical findings, potential underlying pathogenesis, and therapeutic strategy of hypercoagulability and thromboembolism in COVID-19, particularly focusing on the COVID-19 patients with preexisting digestive hypercoagulability disease. Frontiers Media S.A. 2021-01-13 /pmc/articles/PMC7838325/ /pubmed/33521013 http://dx.doi.org/10.3389/fmed.2020.587350 Text en Copyright © 2021 Jiang, Mu, Shen and Zhang. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Jiang, Mingshan
Mu, Jingxi
Shen, Silan
Zhang, Hu
COVID-19 With Preexisting Hypercoagulability Digestive Disease
title COVID-19 With Preexisting Hypercoagulability Digestive Disease
title_full COVID-19 With Preexisting Hypercoagulability Digestive Disease
title_fullStr COVID-19 With Preexisting Hypercoagulability Digestive Disease
title_full_unstemmed COVID-19 With Preexisting Hypercoagulability Digestive Disease
title_short COVID-19 With Preexisting Hypercoagulability Digestive Disease
title_sort covid-19 with preexisting hypercoagulability digestive disease
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838325/
https://www.ncbi.nlm.nih.gov/pubmed/33521013
http://dx.doi.org/10.3389/fmed.2020.587350
work_keys_str_mv AT jiangmingshan covid19withpreexistinghypercoagulabilitydigestivedisease
AT mujingxi covid19withpreexistinghypercoagulabilitydigestivedisease
AT shensilan covid19withpreexistinghypercoagulabilitydigestivedisease
AT zhanghu covid19withpreexistinghypercoagulabilitydigestivedisease

Ejemplares similares